Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Kamoshida

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 29, 2024
Nuclear long diameter as a new criterion to distinguish high-grade urothelial carcinoma cells from benign reactive cellsKazuma Sakumo, Juri Tamura, Akihiro Nakamura, et al.
Molecular and Clinical Oncology|July 8, 2017
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancerMadoka Kimura, Fumio Imamura, Takako Inoue, et al.
Biomedical Research (Tokyo, Japan)|January 11, 2007
Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysisShingo Kamoshida, Kana Watanabe, Mai Suzuki, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 15, 2007
The etiological role of allogeneic fetal rejection in pre-eclampsiaHaruki Nishizawa, Kiyoshi Hasegawa, Machiko Suzuki, et al.
American Journal of Cancer Research|September 19, 2014
High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapyAkito Tashiro, Shigenobu Tatsumi, Risa Takeda, et al.
Oncology Reports|October 8, 2005
Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancerShingo Kamoshida, Kazuya Shiogama, Ryoichi Shimomura, et al.
Acta Cytologica|March 29, 2022
Urinary Podocyte Count as a Potential Routine Laboratory Test for Glomerular Disease: A Novel Method Using Liquid-Based Cytology and Immunoenzyme StainingJunichi Sakane, Hirotsugu Kitayama, Takashi Inoue, et al.
Oncology Reports|September 14, 2006
Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organsShingo Kamoshida, Mai Suzuki, Yoichi Sakurai, et al.
Annals of Diagnostic Pathology|February 4, 2010
Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinomaNaoki Ogane, Masanori Yasuda, Michio Shimizu, et al.
Breast Cancer Research and Treatment|March 28, 2014
Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancerYumi Hashimoto, Shigenobu Tatsumi, Risa Takeda, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 29, 2024
Nuclear long diameter as a new criterion to distinguish high-grade urothelial carcinoma cells from benign reactive cellsKazuma Sakumo, Juri Tamura, Akihiro Nakamura, et al.
Molecular and Clinical Oncology|July 8, 2017
Protein and mRNA expression of folic acid-associated enzymes as biomarkers for the cytotoxicity of the thymidylate synthase-targeted drugs, pemetrexed and S-1, in non-small cell lung cancerMadoka Kimura, Fumio Imamura, Takako Inoue, et al.
Biomedical Research (Tokyo, Japan)|January 11, 2007
Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysisShingo Kamoshida, Kana Watanabe, Mai Suzuki, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 15, 2007
The etiological role of allogeneic fetal rejection in pre-eclampsiaHaruki Nishizawa, Kiyoshi Hasegawa, Machiko Suzuki, et al.
American Journal of Cancer Research|September 19, 2014
High expression of organic anion transporter 2 and organic cation transporter 2 is an independent predictor of good outcomes in patients with metastatic colorectal cancer treated with FOLFOX-based chemotherapyAkito Tashiro, Shigenobu Tatsumi, Risa Takeda, et al.
Oncology Reports|October 8, 2005
Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancerShingo Kamoshida, Kazuya Shiogama, Ryoichi Shimomura, et al.
Acta Cytologica|March 29, 2022
Urinary Podocyte Count as a Potential Routine Laboratory Test for Glomerular Disease: A Novel Method Using Liquid-Based Cytology and Immunoenzyme StainingJunichi Sakane, Hirotsugu Kitayama, Takashi Inoue, et al.
Oncology Reports|September 14, 2006
Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organsShingo Kamoshida, Mai Suzuki, Yoichi Sakurai, et al.
Annals of Diagnostic Pathology|February 4, 2010
Clinicopathological implications of expressions of hypoxia-related molecules in esophageal superficial squamous cell carcinomaNaoki Ogane, Masanori Yasuda, Michio Shimizu, et al.
Breast Cancer Research and Treatment|March 28, 2014
Expression of organic anion-transporting polypeptide 1A2 and organic cation transporter 6 as a predictor of pathologic response to neoadjuvant chemotherapy in triple negative breast cancerYumi Hashimoto, Shigenobu Tatsumi, Risa Takeda, et al.
Pageof 7